Progyny earnings were $56.6M for the trailing 12 months ending Sep 30, 2025, with 4.8% growth year over year. The latest PGNY earnings report on Sep 30, 2025 announced Q3 2025 earnings of $13.9M, down 19% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PGNY reported annual earnings of $54.3M, with -12.4% growth.
PGNY past earnings growth
How has PGNY's earnings growth performed historically?
On PGNY's earnings call on Invalid Date, Progyny (NASDAQ: PGNY) reported Q3 2025 earnings per share (EPS) of $0.16, up 33.33% year over year. Total PGNY earnings for the quarter were $13.86 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.12.
As of the last Progyny earnings report, Progyny is currently profitable. Progyny's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $56.57 million, a 1.23% decrease year over year.
What was PGNY's earnings growth in the past year?
As of Progyny's earnings date in Invalid Date, Progyny's earnings has grown 4.84% year over year. This is 22.74 percentage points lower than the US Health Information Services industry earnings growth rate of 27.58%. PGNY earnings in the past year totalled $56.57 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.